The article in this SIG 6 activity focuses on the audiologic variations seen among
patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a
large amount of audiologic outcome variability among the two patients examined,
despite similar demographic factors, drug treatments, and types of cancer. Factors
relating to ototoxic susceptibility are discussed, and the importance of otoxicity
monitoring programs for early detection of audiologic change is highlighted
Learning
Outcomes
You
will be able to:
- describe risk factors for cisplatin ototoxicity and the range of possible
audiologic outcomes following cisplatin chemotherapy
Assessment
Type
Self-assessment—Think
about what you learned and report on the Completion Form how you will use your
new knowledge.
Article in This Course
- A Tale of Two Susceptibilities: Cisplatin Ototoxicity by Variability in Similar Patients by
Amy Custer, published in SIG 6, November 14, 2022
